Hilmar Bading | Neuroscience | Best Researcher Award

Prof Dr Hilmar Bading | Neuroscience | Best Researcher Award 

 Professor and Head of Department at Heidelberg University, Germany

 

Professor Dr. Hilmar Bading is a distinguished neurobiologist currently serving as a Professor and Chair of the Department of Neurobiology at Heidelberg University, Germany. He is also the Director of the Interdisciplinary Center for Neurosciences (IZN) at the same institution.

professional profile 

scopus

🎓 Education

Professor Bading completed his medical degree at Heidelberg University in 1984. He earned his doctorate (Dr. med.) under the supervision of Professor Wilhelm Hasselbach, with a focus on calcium transport ATPase in muscle at the Max-Planck-Institut für medizinische Forschung, Heidelberg.

💼 Work Experience

Professor Bading has an extensive academic and research career. He has held key positions including Group Leader at the MRC Laboratory of Molecular Biology in Cambridge, England (1993-2001), and postdoctoral fellowships at Harvard Medical School, USA, and the Max-Planck-Institut für molekulare Genetik, Berlin. Since 2001, he has led the Department of Neurobiology at Heidelberg University. Additionally, he is the scientific founder of FundaMental Pharma GmbH and the founder of the Hilmar Bading Stiftung BrainAid.

🔬 Research Focus

His research primarily revolves around the molecular mechanisms that regulate gene expression in neurons, particularly focusing on the role of nuclear calcium in neuroprotection and neurodegeneration. His groundbreaking work has significantly advanced our understanding of how synaptic activity influences gene expression in the nervous system.

🏆 Awards and Honors

Professor Bading’s contributions to science have been widely recognized. He has received several prestigious awards, including the Wolfgang-Paul-Prize from the Alexander von Humboldt-Foundation (2001), an ERC Advanced Grant (2008), and an ERC Proof-of-Concept Grant (2015). In 2019, he was elected as a member of the Leopoldina, the German National Academy of Sciences.

🏅 Memberships

He has been an active member of several prominent scientific boards and commissions, including the Scientific Advisory Board of the Spemann Graduate School of Biology and Medicine at the University of Freiburg, the Commission of the International Max-Planck Research Schools, and the Wellcome Trust Neuroscience Panel in London.

👨‍🏫 Teaching Experience

With a commitment to nurturing the next generation of scientists, Professor Bading has supervised over 25 PhD students as the principal supervisor and co-supervised an additional 50 PhD students. His dedication to teaching is also reflected in his guidance of approximately 80 Master’s and Bachelor’s theses over the past decade.

🔍 Skills

Professor Bading’s expertise lies in molecular biology, neurobiology, and the study of intracellular signaling pathways. His leadership in academia and industry highlights his ability to translate scientific discoveries into practical applications.

publications

  • Neuron–astrocyte metabolic coupling facilitates spinal plasticity and maintenance of inflammatory pain
    • Year: 2024
    • Journal: Nature Metabolism
    • Authors: Marty-Lombardi, S., Lu, S., Ambroziak, W., Fleming, T., Siemens, J.
    • Emoji: 🧠🔬💡
  • TwinF interface inhibitor FP802 stops loss of motor neurons and mitigates disease progression in a mouse model of ALS
    • Year: 2024
    • Journal: Cell Reports Medicine
    • Authors: Yan, J., Wang, Y.M., Hellwig, A., Bading, H.
    • Emoji: 🦠🧬🔬
  • Activin A targets extrasynaptic NMDA receptors to ameliorate neuronal and behavioral deficits in a mouse model of Huntington disease
    • Year: 2023
    • Journal: Neurobiology of Disease
    • Authors: Nassrallah, W.B., Ramandi, D., Cheng, J., Bading, H., Raymond, L.A.
    • Emoji: 🧠💉🧩
  • The Disruption of NMDAR/TRPM4 Death Signaling with TwinF Interface Inhibitors: A New Pharmacological Principle for Neuroprotection
    • Year: 2023
    • Journal: Pharmaceuticals
    • Authors: Yan, J., Bading, H.
    • Emoji: 💊🧬🔒
  • Expression of the primate-specific LINC00473 RNA in mouse neurons promotes excitability and CREB-regulated transcription
    • Year: 2023
    • Journal: Journal of Biological Chemistry
    • Authors: Pruunsild, P., Bengtson, C.P., Loss, I., Lohrer, B., Bading, H.
    • Emoji: 🧬🧠📈
  • Ryanodine Receptor Mediated Calcium Release Contributes to Ferroptosis Induced in Primary Hippocampal Neurons by GPX4 Inhibition
    • Year: 2023
    • Journal: Antioxidants
    • Authors: Gleitze, S., Ramírez, O.A., Vega-Vásquez, I., Paula-Lima, A., Hidalgo, C.
    • Emoji: 🧪🧬💥
  • Neuronal nuclear calcium signaling suppression of microglial reactivity is mediated by osteoprotegerin after traumatic brain injury
    • Year: 2022
    • Journal: Journal of Neuroinflammation
    • Authors: Fröhlich, A., Olde Heuvel, F., Rehman, R., Bading, H., Roselli, F.
    • Emoji: 🧠⚕️🔧
  • N-methyl-D-aspartate Receptor-mediated Preconditioning Mitigates Excitotoxicity in Human Induced Pluripotent Stem Cell-derived Brain Organoids
    • Year: 2022
    • Journal: Neuroscience
    • Authors: Bauersachs, H.G., Bengtson, C.P., Weiss, U., Pruunsild, P., Bading, H.
    • Emoji: 🧪🧠🌱
  • Dysregulation of Npas4 and Inhba expression and an altered excitation-inhibition balance are associated with cognitive deficits in DBA/2 mice
    • Year: 2022
    • Journal: Learning and Memory
    • Authors: Oberländer, K., Witte, V., Mallien, A.S., Bengtson, C.P., Bading, H.
    • Emoji: 🧠🧩📉
  • Disrupted expression of mitochondrial NCLX sensitizes neuroglial networks to excitotoxic stimuli and renders synaptic activity toxic
    • Year: 2022
    • Journal: Journal of Biological Chemistry
    • Authors: Hagenston, A.M., Yan, J., Bas-Orth, C., Sekler, I., Bading, H.
    • Emoji: 🧬⚠️🧠

 

Athanasia Chatziefstathiou | Neuroscience | Best Researcher Award

Mrs  Athanasia Chatziefstathiou |  Neuroscience | Best Researcher Award 

PhD candidate at Aristotle University of Thessaloniki, Greece

 

Athanasia Chatziefstathiou, born on January 30, 1995, is a PhD candidate at the Faculty of Sciences, School of Biology, Aristotle University of Thessaloniki, Greece. She specializes in molecular biology, with a focus on neurodegenerative diseases, particularly the identification and functional verification of new molecular targets in blood-cerebrospinal fluid and exosomes from affected patients. Her research is driven by a passion for unraveling the molecular mechanisms underlying neurological disorders.

professional profile:

Education 🎓

Athanasia Chatziefstathiou is a Ph.D. candidate at the Faculty of Sciences, School of Biology, Aristotle University of Thessaloniki, Greece. Her doctoral research focuses on the “Identification and functional verification of new molecular targets of blood – cerebrospinal fluid and exosomes from patients with neurodegenerative diseases.” She holds a Master’s degree (M.Sc.) in Applied Genetics and Biodiagnosis from the same institution, which she completed in 2020. Her master’s thesis was centered on the “Optimization of protein assays for the diagnosis of neurodegenerative diseases.” Prior to that, she earned her Bachelor’s degree (B.Sc.) in Biology from the Faculty of Sciences, School of Biology, Aristotle University of Thessaloniki in 2018.

Work Experience 💼

From 2024 to 2026, Athanasia is a key member of the Greek Research Team in the IKYDA Programme, which promotes scientific cooperation between Greece and Germany. Her research within this program explores “The role of neuronal exosomes in Prion pathology.” In 2021, she served as a Research Assistant at the Faculty of Sciences, School of Biology, Aristotle University of Thessaloniki, where she contributed to the “Development of advanced biomarker technology for the differential diagnosis of Parkinson’s Disease,” a project funded by the European Union and Greek national funds. Additionally, during the same year, she worked as a Supporting Teaching Assistant at Aristotle University, aiding in the “Supporting Teaching” initiative to enhance educational activities. She also gained international experience through an ERASMUS+ Internship in Germany, where she focused on optimizing protein assays for the diagnosis of neurodegenerative diseases. In 2020, Athanasia contributed to monitoring the SARS-CoV-2 virus at the urban wastewater unit of EYATH, as a Research Assistant at Aristotle University. Her earlier experiences include internships at the Biomedical Research Foundation of the Academy of Athens (BRFAA) in 2019, where she studied pathways in Parkinson’s Disease, and at the Biomedical Sciences Research Center “Alexander Fleming” in 2018, where she used Drosophila melanogaster as a model organism for neurodegenerative diseases.

Skills & Expertise 🧠

Athanasia has developed a strong skill set in molecular biology techniques, particularly in the context of neurodegenerative disease research. She is proficient in optimizing protein assays and advancing biomarker technology. Her data analysis skills include the use of tools such as Tableau, MySQL, Python, and R. Additionally, she has expertise in using Drosophila melanogaster as a model organism for neuroscience research.

Awards & Honors 🏆

Her academic and research excellence has been recognized through several awards. From 2022 to 2025, she received the H.F.R.I. Scholarships for PhD Candidates, securing an Individual Fellowship for her doctoral studies. In 2023, she was honored with the 10th Hellenic Academy of Neuroimmunology award for the best research announcement.

Other Scientific Activities & Training 📚

Athanasia is committed to continuous learning and professional development. In 2024, she participated in the Data Science Summer School, where she honed her skills in Tableau, MySQL, and Python for data analysis. In 2021, she completed the 2nd LAS Core Modules Course organized by BSRC “Alexander Fleming” in line with P.D. 56/2013. Earlier, in 2020, she completed the “Data Science R Basics” course offered by DataCamp, further expanding her expertise in data science.

Conclusion

Athanasia Chatziefstathiou is a promising researcher with a strong academic background, extensive research experience, and notable achievements in the field of neurodegenerative diseases. Her focus on molecular biology, particularly in the context of neurodegenerative diagnostics, positions her as a valuable contributor to this field. Given her achievements, dedication, and ongoing research, Athanasia is a suitable candidate for the Best Researcher Award. Her work has the potential to significantly impact our understanding of neurodegenerative diseases, making her a deserving contender for this recognition.

Carmela Conte | Neuroscience | Best Extension Activity Award

Dr Carmela Conte | Neuroscience | Best Extension Activity Award

Aggregate Professor at Department of Pharmaceutical Sciences. University of Perguia ,Italy

 

Carmela Conte is an Italian biochemist and Aggregate Professor at the University of Perugia. She holds a Master’s in Biological Sciences (1994) 🎓, a PhD in Medical Embryology (2000) 🧬, and a specialization in Chemistry and Food Technology (2002) 🧑‍🔬. Recently, she achieved National Habilitation as an Associate Professor in Biochemistry (2023) 🏅.Since 2007, she has taught Biochemistry and Molecular Biology at the University of Perugia 📚. Her research focuses on Parkinson’s disease and neuroinflammation 🧠, with notable work conducted at VUMC Medical University of Amsterdam 🧪.Carmela is a member of the European Society for Neurochemistry and the International Parkinson and Movement Disorder Society 🌐. She serves as a reviewer editor for Frontiers in Neuroscience and reviews for several journals 📝. Her contributions include numerous research papers and conference presentations 🗒️.She also participates in institutional committees at the University of Perugia, collaborating with scientists across Europe to advance neurodegeneration research 🤝.

 

professional profile:

scopus\

 

Education 🎓

Carmela Conte holds a Master’s Degree in Biological Sciences from the University of Perugia, completed on November 3, 1994. She pursued a PhD in Medical Embryology through a joint program of the Universities of Perugia and Ferrara, finishing on January 19, 2000. Additionally, she specialized in Chemistry and Food Technology at the University of Perugia from November 1, 2000, to November 1, 2002. Recently, she obtained her National Habilitation as an Associate Professor in Biochemistry, effective from September 29, 2023.

Work Experience 🏢

Since September 7, 2007, Carmela has served as an Aggregate Professor in Biochemistry at the University of Perugia, teaching courses in General and Systematic Biochemistry, Medical Applied Biochemistry, and Molecular Biology. Her dedication to teaching is complemented by her involvement in research, particularly evident during her teaching and training mobility at VUMC Medical University of Amsterdam from June 24 to July 5, 2019, where she conducted research on the role of Toll-like receptors in Parkinson’s disease.

Skills and Expertise 🧠

Carmela’s expertise spans several critical areas, including neurodegenerative diseases, animal models of neurodegenerative diseases, signal transduction, molecular biology, and cell biology. Her research skills are deeply rooted in her comprehensive understanding of these fields, making significant contributions to the scientific community.

Awards and Honors 🏆

Carmela has received numerous accolades for her work. She is a reviewer editor for Frontiers in Neuroscience, specifically in the section “Neurodegeneration,” and serves as an ad hoc reviewer for several prestigious journals such as Amino Acids, The Cerebellum, and Neurochemical Research. Additionally, she has been a guest editor for Molecules and Cells journals, focusing on special issues and topic collections in the field of neurodegenerative diseases.

Memberships and Networks 🌐

An active member of the European Society for Neurochemistry since September 7, 2007, Carmela also joined the International Parkinson and Movement Disorder Society on March 17, 2022. These memberships reflect her commitment to staying connected with the broader scientific community and contributing to ongoing research and developments in her field.

Teaching Experience 📚

Carmela boasts over 15 years of teaching experience at the University of Perugia, where she has imparted knowledge in General and Systematic Biochemistry, Medical Applied Biochemistry, and Molecular Biology. She also plays a pivotal role in the PhD program in Pharmaceutical Sciences as a member of the Teaching Board, showcasing her dedication to nurturing the next generation of scientists.

Research Focus 🔬

Carmela’s research is primarily focused on neurodegenerative diseases, with particular attention to Parkinson’s disease, neuroinflammation, synucleinopathies, and oxidative stress. Her projects include studying the role of Toll-like receptors in Parkinson’s disease and investigating the effects of oxidative stress and neuroinflammation on neurodegeneration. Her work delves into the pathological mechanisms of synucleinopathies, contributing valuable insights to the field.

Scientific Contributions 📝

Throughout her career, Carmela has presented her research at numerous scientific meetings and conferences, including the European Society for Neurochemistry and the European Biotechnology Congress. Her notable presentations include studies on antioxidant defense mechanisms, Toll-like receptors, and vitamin D3 in neurodegenerative contexts. She has authored several influential research papers, further establishing her as a leading figure in her field.

Conclusion

Carmela Conte’s extensive education, significant research contributions, active professional memberships, and numerous collaborations make her a deserving candidate for the Best Researcher Award. Her dedication to advancing knowledge in the field of neurodegenerative diseases, coupled with her active participation in the scientific community, highlights her as a leading researcher whose work has had a profound impact on the field.

publication: